Latest News about general
Recent news which mentions general
Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
November 14, 2024
From Benzinga
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
November 14, 2024
From Benzinga
GTA 5 Joins November's PlayStation Plus Lineup With Other Fan-Favorites
November 14, 2024
From Benzinga
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
November 14, 2024
From Benzinga
Campbell Soup Rao's Brand Growth Strong And US Sales Trend Improving, Analyst Upgrades Stock
November 14, 2024
From Benzinga
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14, 2024
From Benzinga
Inseego's Turnaround Gains Traction: New Products And Partnerships to Fuel Future Growth, Says Analyst
November 14, 2024
From Benzinga
What's Going On With Beyond Meat Stock Today?
November 14, 2024
From Benzinga
What's Going On With Ford Motor Stock Today?
November 14, 2024
From Benzinga
What's Going On With Unilever Stock Today?
November 14, 2024
From Benzinga
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
November 14, 2024
From Benzinga
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
November 14, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.